Skip to main content

Table 2 Multivariable-adjusted odds ratio for the development of chronic pancreatitis in participants with fatty pancreas

From: Impact of fatty pancreas and lifestyle on the development of subclinical chronic pancreatitis in healthy people undergoing a medical checkup

 

Chronic pancreatitis

No chronic pancreatitis

Univariate analysis

n = 9933

Multivariable analysis*

n = 9933

n = 92

n = 9841

Crude OR with 95% CI

AUC

Adjusted OR with 95% CI

Tolerance

VIF

Condition index

AUC

Fat accumulation

 Normal pancreas, n (%)

80 (0.82)

9630 (99.18)

Reference

0.555

Reference

0.982

1.018

3.139

0.802

 Fatty pancreas, n (%)

12 (5.38)

211 (94.62)

6.846 (3.676, 12.750)

 

3.957 (2.043, 7.664)

 

Demographics

 Age, mean (SD)

54.72 (9.68)

46.67 (8.67)

1.095 (1.073, 1.118)

0.728

1.099 (1.072, 1.127)

0.821

1.218

 

 Women, n (%)

20 (0.41)

4857 (99.59)

Reference

0.638

Reference

0.600

1.667

 Men, n (%)

72 (1.42)

4984 (98.58)

3.508 (2.134, 5.767)

 

1.943 (1.065, 3.542)

 

 Body mass index, mean (SD)

22.93 (2.77)

22.27 (3.05)

1.067 (1.004, 1.133)

0.575

0.971 (0.890, 1.059)

0.668

1.500

 Systolic blood pressure, mean (SD)

115.7 (15.04)

109.17 (14.42)

1.027 (1.015, 1.039)

0.629

0.999 (0.978, 1.020)

0.429

2.329

 Pulse pressure, mean (SD)

47.39 (9.83)

44.07 (8.75)

1.038 (1.018, 1.060)

0.605

1.010 (0.980, 1.042)

0.529

1.889

Laboratory data

 AST/ALT, mean (SD)

1.05 (0.33)

1.15 (0.36)

0.436 (0.232, 0.820)

0.581

0.444 (0.203, 1.001)

0.728

1.374

 

 Gamma-glutamyltransferase, mean (SD)

56.01 (68.97)

36.11 (46.96)

1.004 (1.002, 1.006)

0.644

 

 LDL/HDL, mean (SD)

2.03 (0.69)

1.96 (0.7)

1.131 (0.850, 1.504)

0.529

0.878 (0.633, 1.220)

0.772

1.295

 Fasting blood glucose, mean (SD)

101.55 (13.47)

97.18 (14.24)

1.011 (1.004, 1.019)

0.631

0.999 (0.979, 1.019)

0.391

2.558

 Hemoglobin A1c, mean (SD)

5.72 (0.49)

5.55 (0.51)

1.424 (1.140, 1.779)

0.611

0.972 (0.557, 1.697)

0.403

2.480

Lifestyle factors

 Ethanol intake, n (%)

 None, n (%)

46 (0.68)

6684 (99.32)

Reference

0.605

Reference

0.765

1.307

 

 1–139 g/week, n (%)

10 (0.97)

1018 (99.03)

1.427 (0.718, 2.837)

 

0.971 (0.476, 1.977)

 

 140–279 g/week, n (%)

18 (1.27)

1396 (98.73)

1.874 (1.083, 3.241)

1.084 (0.597, 1.971)

 ≤ 280 g/week, n (%)

18 (2.37)

743 (97.67)

3.520 (2.031, 6.102)

1.933 (1.023, 3.652)

 Smoking, n (%)

 Brinkman index = 0, n (%)

55 (0.7)

7832 (99.3)

Reference

0.607

Reference

0.856

1.169

 

 0 < Brinkman index < 200, n (%)

2 (0.62)

323 (99.38)

0.882 (0.214, 3.631)

 

1.415 (0.337, 5.936)

 

 200 ≤ Brinkman index < 400, n (%)

9 (1.75)

504 (98.25)

2.543 (1.250, 5.175)

3.529 (1.657, 7.517)

 400 ≤ Brinkman index, n (%)

26 (2.15)

1182 (97.85)

3.132 (1.957, 5.014)

1.922 (1.145, 3.224)

  
  1. OR odds ratio, 95% CI 95% interval estimates with confidence limits, AUC area under the curve, VIF variance inflation, AST/ALT aspartate aminotransferase to alanine aminotransferase ratio, LDL/HDL low-density lipoprotein to high-density lipoprotein ratio
  2. *Adjusted for age, sex, body mass index, systolic blood pressure, pulse pressure, AST/ALT, LDL/HDL, log-transformed fasting blood glucose concentration, log-transformed hemoglobin A1c, alcohol intake status, and Brinkman index